Digital Access

Digital Access
Access daily-chronicle.com and all Shaw Media Illinois content from all your digital devices and receive breaking news and updates from around the area.

Home Delivery

Home Delivery
Local news, prep sports, Chicago sports, local and regional entertainment, business, home and lifestyle, food, classified and more!

Text Alerts

Text Alerts
Choose your news! Select the text alerts you want to receive: breaking news, prep sports scores, school closings, weather, and more.

Email Newsletters

Email Newsletters
We'll deliver news & updates to your inbox. Sign up for free e-newsletters today.
Letters to the Editor

Letter: For-profit health care system will never be about patients

For-profit health care system will never be about patients

To the Editor:

Eric Olson’s thoughtful column last weekend on the high cost of prescription drugs provided local illustrations to an issue affecting all Americans.

However, I believe Olson’s solution of “collaboration between the parties” was off the mark. How do you collaborate with gangsters, extortionists and killers?

The Canadian doctors who invented insulin in 1922 sold the patent for $1 so that the drug would be available to everyone. Today, Eli Lilly charges $300 a dose and documented cases of individuals dying because they couldn’t afford their insulin are on the rise.

About 250,000 Americans have died in the opioid epidemic even as the drug dealers long knew the murderous effects of their profitable pain-killers. Another 30,000 Americans die annually because they don’t see a doctor when they should to avoid bills they can’t pay.

Meanwhile, 500,000 Americans go bankrupt every year due to medical costs. While Olson is to be commended for putting the voices of real people in our community into the broader conversation, a for-profit health care system will always emphasize profit over health care.

Eliminating the wasteful middlemen in health insurance with Medicare for All is a good first step in moving toward a system of health care for people not profits. Then we need to deal harshly with the pharmaceutical profiteers.

Dave Rathke

DeKalb

Loading more